New Schizophrenia Research from Janssen Scientific Affairs LLC Described (Long-term efficacy and safety of paliperidone 6-month formulation: An open-label extension of a double-blind study in adult patients with schizophrenia).

Předmět:	PEOPLE with schizophrenia ARIPIPRAZOLE SCHIZOPHRENIA MENTAL illness SAFETY MEDICAL research
Zdroj:	Mental Health Weekly Digest; 11/6/2023, p1559-1559, 1p
Abstrakt:	Antipsychotics, Atypical Antipsychotics, Business, Clinical Research, Clinical Trials and Studies, Drugs and Therapies, Health and Medicine, Mental Health Diseases and Conditions, Paliperidone Therapy, Pharmaceutical Companies, Pharmaceuticals, Psychiatry, Psychotherapeutic Agents, Schizophrenia Keywords: Antipsychotics; Atypical Antipsychotics; Business; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Mental Health Diseases and Conditions; Paliperidone Therapy; Pharmaceutical Companies; Pharmaceuticals; Psychiatry; Psychotherapeutic Agents; Schizophrenia EN Antipsychotics Atypical Antipsychotics Business Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Mental Health Diseases and Conditions Paliperidone Therapy Pharmaceutical Companies Pharmaceuticals Psychiatry Psychotherapeutic Agents Schizophrenia 1559 1559 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- New study results on schizophrenia have been published. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu